Atlas Trials

Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis

Clinical trial NCT06478602 · COMPLETED

Trial details

NCT number
NCT06478602
Sponsor
Cristian Ichim
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Liver Cirrhosis
Start date
2024-08-05
Primary completion
2024-12-30
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.